pyridostigmine bromide has been researched along with Batten Turner Congenital Myopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beeson, D; Feng, L; Gunny, R; Illingworth, MA; Main, M; Manzur, A; Muntoni, F; Pitt, M; Robb, SA; Sewry, CA; Vorstman, E | 1 |
| Huber, A | 1 |
2 other study(ies) available for pyridostigmine bromide and Batten Turner Congenital Myopathy
| Article | Year |
|---|---|
RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine.
Topics: Biopsy; Cholinesterase Inhibitors; Codon, Nonsense; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Muscle Fatigue; Muscles; Myotonia Congenita; Pyridostigmine Bromide; Ryanodine Receptor Calcium Release Channel; Siblings; Treatment Outcome | 2014 |
[Therapy of peripheral oculomotor paralysis].
Topics: Adrenal Cortex Hormones; Antithyroid Agents; Blepharoptosis; Cholinesterase Inhibitors; Diplopia; Electromyography; Electrooculography; Endocrine System Diseases; Exophthalmos; Eye Diseases; Humans; Muscular Diseases; Myasthenia Gravis; Myositis; Myotonia Congenita; Neuromuscular Diseases; Oculomotor Muscles; Ophthalmoplegia; Orthoptics; Pyridostigmine Bromide; Strabismus | 1969 |